chr2-172556200-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002610.5(PDK1):c.50C>A(p.Pro17Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000636 in 1,414,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002610.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDK1 | NM_002610.5 | c.50C>A | p.Pro17Gln | missense_variant | 1/11 | ENST00000282077.8 | NP_002601.1 | |
LOC124900513 | XR_007087304.1 | n.265G>T | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDK1 | ENST00000282077.8 | c.50C>A | p.Pro17Gln | missense_variant | 1/11 | 1 | NM_002610.5 | ENSP00000282077 | P1 | |
PDK1-AS1 | ENST00000442417.5 | n.330G>T | non_coding_transcript_exon_variant | 1/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000634 AC: 8AN: 1262510Hom.: 0 Cov.: 31 AF XY: 0.00000485 AC XY: 3AN XY: 618286
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2024 | The c.50C>A (p.P17Q) alteration is located in exon 1 (coding exon 1) of the PDK1 gene. This alteration results from a C to A substitution at nucleotide position 50, causing the proline (P) at amino acid position 17 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at